Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A3777 Rotigotine hydrochlorideSummary: Agonist of dopamine D2/D3 receptor
- A3778 RS 127445Summary: 5-HT2B receptor antagonist,high affinity
- A3811 SEA04004 CitationTarget: Na /Ca2 Exchangers (NCXs)Summary: Specific inhibitor of Na+/Ca2+ exchange
- A3862 TC-DAPK 6Summary: DAPK inhibitor
- A3873 TianeptineSummary: 5-HT facilitator
- A3874 Tiotropium BromideTarget: AChRSummary: MAChR M antagonist
- A3900 Umeclidinium bromideSummary: MAChR antagonist
- A3918 VilazodoneSummary: Combined SSRI and 5-HT1A receptor partial agonist
- A3919 Vilazodone HydrochlorideSummary: Combined SSRI and 5-HT1A receptor partial agonist
- A3926 VortioxetineTarget: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERTSummary: 5-HT receptors antagonist